Here, we showed that HSD17B13 was more highly expressed in the livers of NAFLD patients, and high expression was induced in the livers of murine NAFLD models and cultural hepatocytes treated using various etiologies. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.